FDA brass wants to temper enthusiasm over ‘real-world evidence’

I

n a cautiously worded essay, the Food and Drug Administration commissioner and more than a dozen other agency officials are trying to temper enthusiasm for a controversial provision in the 21st Century Cures Act, which was signed into law on Tuesday by President Obama.

The subject of their treatise is real-world evidence, a euphemism for various sorts of data that the law would allow the agency to use for approving additional uses of medicines, as well as for any follow-up studies that may be required. Such evidence could include electronic health records, observational studies, ongoing safety monitoring, claims data, and patient registries, among other things.

 

Source; https://www.statnews.com/pharmalot/2016/12/13/fda-clinical-trials-evidence-cures/

Leave a Reply